本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aurinia Pharmaceuticals Inc

8.24
+0.03100.38%
成交量:22.08万
成交额:181.56万
市值:11.26亿
市盈率:206.02
高:8.31
开:8.19
低:8.14
收:8.21
数据加载中...
2020/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/18

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/10

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]